Mueller, Ruediger B. http://orcid.org/0000-0003-1997-5564
Schulze-Koops, Hendrik
Furst, Daniel E.
Cohen, Stanley B.
Kwok, Kenneth
Wang, Lisy
Killeen, Tim http://orcid.org/0000-0001-8246-4957
von Kempis, Johannes
Funding for this research was provided by:
Pfizer Inc
Article History
Received: 11 February 2021
Revised: 26 August 2021
Accepted: 2 September 2021
First Online: 1 January 2022
Declarations
:
: The study was conducted in accordance with International Council for Harmonization Guidelines for Good Clinical Practice and the Declaration of Helsinki. The study protocol was reviewed and approved by the Institutional Review Boards and/or an independent ethics committee at each study center, and all patients provided written informed consent.
: Not applicable.
: RBM has received consulting fees or other remuneration from Pfizer Inc. HS-K has received consulting fees or other remuneration from Pfizer Inc. DEF has received consulting fees or other remuneration from AbbVie, Amgen, Boehringer Ingelheim, Corbus, NIH, Novartis, Pfizer Inc, and Roche-Genentech. SBC has received consulting fees or other remuneration from AbbVie, Amgen, Boehringer Ingelheim, Gilead, Merck, and Pfizer Inc. KK and LW are employees and shareholders of Pfizer Inc. TK is an employee of Pfizer AG and shareholder of Pfizer Inc. JvK has received consulting fees or other remuneration from AbbVie, Bristol-Myers Squibb, Menarini, Pfizer Inc, and Sanofi.